Autolus Therapeutics plc (NASDAQ:AUTL) Q4 2025 Earnings Call Transcript

Autolus Therapeutics plc (NASDAQ:AUTL) Q4 2025 Earnings Call Transcript March 27, 2026

Autolus Therapeutics plc misses on earnings expectations. Reported EPS is $-0.34 EPS, expectations were $-0.25993.

Operator: Good day, and thank you for standing by. Welcome to the Autolus Fourth Quarter 2025 and Full Year 2025 Financial Results Conference Call. [Operator Instructions] Please be advised today’s conference is being recorded. I would now like to hand the conference over to your speaker...